Muutke küpsiste eelistusi

Clinical Practice Protocols in Oncology Nursing [Pehme köide]

4.00/5 (1 hinnangut Goodreads-ist)
,
  • Formaat: Paperback / softback, 675 pages, kaal: 1361 g
  • Ilmumisaeg: 27-Jul-2011
  • Kirjastus: Jones and Bartlett Publishers, Inc
  • ISBN-10: 1449647529
  • ISBN-13: 9781449647520
Teised raamatud teemal:
Clinical Practice Protocols in Oncology NursingSuurem pilt
  • Formaat: Paperback / softback, 675 pages, kaal: 1361 g
  • Ilmumisaeg: 27-Jul-2011
  • Kirjastus: Jones and Bartlett Publishers, Inc
  • ISBN-10: 1449647529
  • ISBN-13: 9781449647520
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9781449647520.html
Märksõnad:
This is a comprehensive, step-by-step guide to care for the cancer patient, from administrative to chemotherapy delivery, arranged alphabetically by disease. This book is ideal for oncology nurses, oncology nurses in training, and administrators of cancer care clinics and hospitals. A unique and practical reference book!

Includes a companion CR-ROM with printable protocols and forms!
Dedication iii
Disclaimer iv
About the Authors v
Preface vi
AcknowLegments viii
Anal Cancer
1(5)
Metastatic Disease and/or Salvage Chemotherapy
5(1)
Biliary Tract Cancer
6(3)
Bladder Cancer
9(18)
Combination Regimens
11(13)
Single-Agent Regimens
24(3)
Bone Metastasis
27(4)
Brain Cancer
31(10)
Adjuvant Therapy
33(1)
Combination Regimens
33(2)
SingLe-Agent Regimens
35(1)
Advanced Disease
36(1)
Combination Regimens
36(1)
Single-Agent Regimens
37(4)
Breast Cancer
41(32)
Neoadjuvant Therapy
44(1)
Combination Regimens
44(2)
Adjuvant Therapy
46(1)
Combination Regimens
46(21)
Single-Agent Regimens
67(6)
Metastatic Breast Cancer
73(52)
Combination Regimens
79(28)
Single-Agent Regimens
107(18)
Cancer Of Unknown Primary
125(8)
Carcinoid Tumors
133(6)
Combination Regimens
134(3)
SingLe-Agent Regimens
137(2)
Cervical Cancer
139(21)
Combination Regimens
142(12)
Single-Agent Regimens
154(6)
Colorectal Cancer
160(10)
Neoadjuvant Combined Modality Therapy For Rectal Cancer
161(1)
Combination Regimens
161(3)
Adjuvant Therapy
164(6)
Colorectal Cancer
170(44)
Metastatic Disease
175(1)
Combination Regimens
175(32)
Hepatic Artery Infusion (HAI)
207(1)
SingLe-Agent Regimens
208(6)
Endometrial Cancer
214(15)
Combination Regimens
216(8)
Single-Agent Regimens
224(5)
Esophageal Cancer
229(10)
Combination Regimens
231(3)
Metastatic Disease
234(4)
SingLe-Agent Regimens
238(1)
Gastric Cancer
239(19)
Adjuvant Therapy
242(2)
Combination Regimens
244(12)
SingLe-Agent Regimens
256(2)
Gastrointestinal Stromal Tumor (Gist)
258(3)
SingLe-Agent Regimens
259(2)
Head And Neck Cancer
261(24)
Combination Regimens
264(16)
SingLe-Agent Regimens
280(5)
Hepatocellular Cancer
285(4)
SingLe-Agent Regimens
286(3)
Kaposi's Sarcoma
289(8)
Combination Regimens
290(3)
Single-Agent Regimens
293(4)
Leukemia
297(9)
Acute Lymphocytic Leukemia
297(4)
Induction Therapy
301(2)
Consolidation Therapy
303(2)
Maintenance Therapy
305(1)
Cns Prophylaxis
306(6)
Cns Prophylaxis
312(4)
Single-Agent Regimens
314(2)
Leukemia
316(19)
Acute Myelogenous Leukemia
316(2)
Induction Regimens
318(6)
Consolidation Regimens
324(3)
Single-Agent Regimens
327(4)
Relapse AML
331(4)
Leukemia
335(7)
Acute Promyelocytic Leukemia (APL)
335(1)
Single Agents
336(6)
Leukemia
342(15)
Chronic Lymphocytic Leukemia
342(2)
Combination Regimens
344(8)
Single-Agent Regimens
352(5)
Leukemia
357(7)
Chronic Myelogenous Leukemia
357(1)
Combination Regimens
358(1)
Single-Agent Regimens
359(5)
Leukemia
364(4)
Hairy Cell Leukemia
364(4)
Lung Cancer
368(34)
Non-Small Cell Lung Cancer
368(4)
Adjuvant Therapy
372(1)
Combination Therapy
372(2)
Metastatic Disease
374(1)
Combination Regimens
374(19)
Single-Agent Regimens
393(9)
Lung Cancer
402(13)
Small-Cell Lung Cancer
402(2)
Combination Regimens
404(8)
Single-Agent Regimens
412(3)
Lymphoma
415(22)
Hodgkin's Disease
415(3)
Combination Regimens
418(18)
Single-Agent Regimen
436(1)
Lymphoma
437(61)
Non-Hodgkin's Lymphoma
437(6)
Low-Grade
443(1)
Combination Regimens
443(32)
Intermediate-Grade
453(14)
High-Grade
467(7)
Mantle Cell Lymphoma
474(1)
CD20+, B-CELL LYMPHOMAS
475(23)
Salvage Regimens
479(8)
Primary Cns Lymphoma
487(4)
Single-Agent Regimens
491(7)
Malignant Melanoma
498(19)
Adjuvant Therapy
500(2)
Metastatic Disease
502(1)
Combination Regimens
502(11)
Single-Agent Regimens
513(4)
Malignant Mesothelioma
517(7)
Combination Regimens
518(6)
Multiple Myeloma
524(15)
Combination Regimens
526(6)
SingLe-Agent Regimens
532(7)
Myelodysplastic Syndrome
539(8)
SingLe-Agent Regimens
540(7)
Ovarian Cancer
547(15)
Combination Regimens
549(7)
SingLe-Agent Regimens
556(6)
Ovarian Cancer
562(2)
(Germ Cell)
562(1)
Combination Regimens
563(1)
Pancreatic Cancer
564(19)
Locally Advanced Disease
567(1)
Metastatic Disease
568(1)
Combination Regimens
568(13)
Single-Agent Regimens
581(2)
Prostate Cancer
583(24)
Combination Regimens
586(10)
SingLe-Agent Regimens
596(11)
Renal Cell Cancer
607(9)
Combination Regimens
608(3)
SingLe-Agent Regimens
611(5)
Soft Tissue Sarcomas
616(11)
Combination Regimens
618(6)
SingLe-Agent Regimens
624(3)
Testicular Cancer
627(10)
Adjuvant Therapy
629(1)
Advanced Disease
630(5)
SaLvage Regimens
635(2)
Thymoma
637(4)
Thyroid Cancer
641(3)
Combination Regimen
642(1)
SingLe-Agent Regimen
643(1)
Appendix 644(6)
References 650(13)
Index 663